These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1695574)

  • 1. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
    Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M
    Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of D2 dopamine receptors in dopamine-resistant prolactin-secreting rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Lafond J; Beauregard G; Potier M; Collu R
    J Neurochem; 1987 Nov; 49(5):1644-50. PubMed ID: 2959753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling.
    Amlaiky N; Caron MG
    J Neurochem; 1986 Jul; 47(1):196-204. PubMed ID: 2940337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of dopamine receptor agonist binding sites by cations and estradiol in intact pituitary and 7315a tumors.
    Abolfathi Z; Di Paolo T
    Biochem Pharmacol; 1991 Nov; 42(11):2163-9. PubMed ID: 1958234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ; Reches A; MacLeod RM; Login IS
    Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-photoaffinity labeling of the D2-dopamine receptor.
    Kanety H; Fuchs S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
    Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
    Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
    Amlaiky N; Caron MG
    J Biol Chem; 1985 Feb; 260(4):1983-6. PubMed ID: 2579064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of dopamine receptors by cations in 7315a, MtTW15 and estradiol-induced pituitary tumors.
    Coenen K; Di Paolo T
    Biochem Pharmacol; 1990 Sep; 40(6):1373-80. PubMed ID: 2403391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS; Burt DR; Barraclough CA
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
    Bouvier C; Forget H; Lagacé G; Drews R; Sinnett D; Labuda D; Collu R
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
    Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
    Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
    Clagett-Dame M; McKelvy JF
    Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol and guanine nucleotide modulation of dopamine receptor agonist and antagonist binding sites in 7315a pituitary tumors.
    Di Paolo T; Bernier MA
    Biochem Pharmacol; 1988 Jun; 37(12):2373-9. PubMed ID: 3390204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Valerio A; Alberici A; Tinti C; Spano P; Memo M
    J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between dopamine D2 receptors present in a rat pituitary adenoma and in transplantable rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Potier M; Collu R
    J Neurochem; 1990 Mar; 54(3):815-22. PubMed ID: 1968089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and characterization of D2-dopamine receptors in an estrone-induced, prolactin-secreting rat pituitary adenoma.
    Bouvier C; Potier M; Beauregard G; Lafond J; Amlaiky N; Caron MG; Collu R
    J Neurochem; 1986 Nov; 47(5):1653-60. PubMed ID: 3760878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.